I noticed that Michael Weiss, CEO of TG Therapeutics reduced his total share count considerably in 2016. He went from owning 4.5 million shares down to 1.1 million.
Maybe he had to unload them by a certain date, I am not that familiar with shares owned by insiders. Just wanted to bring it to everyone’s attention. maybe it is nothing to be concerned about but I was surprised when I noticed it.
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.